XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 4,413 4,217 13,572 10,884
General and administrative 2,054 1,781 5,239 5,520
Total operating expenses 6,467 5,998 18,811 16,404
Operating loss (6,467) (5,998) (18,811) (16,404)
Other income (expense):        
Foreign exchange gains (losses) 276 9 514 5
Interest income 67 4 88 12
Other income, net 14   1,294 144
Total other income, net 357 13 1,896 161
Loss before taxes (6,110) (5,985) (16,915) (16,243)
Income tax benefit 1,014 998 3,136 2,650
Net loss (5,096) (4,987) (13,779) (13,593)
Dividend on convertible exchangeable preferred shares (50) (50) (151) (151)
Net loss applicable to common shareholders $ (5,146) $ (5,037) $ (13,930) $ (13,744)
Basic and diluted earnings per common share:        
Net loss per share - basic $ (0.42) $ (0.54) $ (1.29) $ (1.60)
Net loss per share - diluted $ (0.42) $ (0.54) $ (1.29) $ (1.60)
Weighted average common shares outstanding basic 12,314,679 9,368,056 10,823,138 8,575,379
Weighted average common shares outstanding diluted 12,314,679 9,368,056 10,823,138 8,575,379